BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 31187923)

  • 21. Nonagenarian Grafts for Liver Transplantation.
    Ghinolfi D; Pezzati D; Rreka E; Balzano E; Catalano G; Coletti L; Tincani G; Carrai P; Petruccelli S; Martinelli C; Aglietti R; Bindi ML; Morganti R; Biancofiore G; De Simone P
    Liver Transpl; 2019 Sep; 25(9):1439-1444. PubMed ID: 31165525
    [No Abstract]   [Full Text] [Related]  

  • 22. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of pure microsteatosis on transplant outcomes after living donor liver transplantation: a matched case-control study.
    Han S; Ko JS; Kwon G; Park C; Lee S; Kim J; Kim G; Kwon CD; Gwak M; Ha S
    Liver Transpl; 2014 Apr; 20(4):473-82. PubMed ID: 24425681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.
    Northup PG; Intagliata NM; Davis JPE; Argo CK; Pelletier SJ
    Transplantation; 2020 Jun; 104(6):1193-1200. PubMed ID: 31577675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation.
    Sharkey FE; Lytvak I; Prihoda TJ; Speeg KV; Washburn WK; Halff GA
    Hum Pathol; 2011 Sep; 42(9):1337-42. PubMed ID: 21420717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Utility of Extended Criteria Donor Livers in High Acuity Liver Transplant Recipients.
    Guorgui J; Ito T; Younan S; Agopian VG; Dinorcia J; Farmer DG; Busuttil RW; Kaldas FM
    Am Surg; 2021 Dec; 87(10):1684-1689. PubMed ID: 34130521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.
    Kollmann D; Goldaracena N; Sapisochin G; Linares I; Selzner N; Hansen BE; Bhat M; Cattral MS; Greig PD; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M
    Liver Transpl; 2018 Nov; 24(11):1512-1522. PubMed ID: 30264930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expansion of the Liver Donor Supply Through Greater Use of Split-Liver Transplantation: Identifying Optimal Recipients.
    Mogul DB; Luo X; Garonzik-Wang J; Bowring MG; Massie AB; Schwarz KB; Cameron AM; Bridges JFP; Segev DL
    Liver Transpl; 2019 Jan; 25(1):119-127. PubMed ID: 30230191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.
    Schlegel A; Kalisvaart M; Scalera I; Laing RW; Mergental H; Mirza DF; Perera T; Isaac J; Dutkowski P; Muiesan P
    J Hepatol; 2018 Mar; 68(3):456-464. PubMed ID: 29155020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Dual-Kidney Liver Transplantation in the United States: A Review of United Network for Organ Sharing/Organ Procurement and Transplantation Network Data Between 2002 and 2012.
    Shekhtman G; Huang E; Danovitch GM; Martin P; Bunnapradist S
    Liver Transpl; 2018 Nov; 24(11):1570-1577. PubMed ID: 29493877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation.
    Nemes B; Gámán G; Polak WG; Gelley F; Hara T; Ono S; Baimakhanov Z; Piros L; Eguchi S
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):841-59. PubMed ID: 26831547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steatotic donor livers: Where is the risk-benefit maximized?
    Hamar M; Selzner M
    Liver Transpl; 2017 Oct; 23(S1):S34-S39. PubMed ID: 28734124
    [No Abstract]   [Full Text] [Related]  

  • 35. Microsteatosis may not interact with macrosteatosis in living donor liver transplantation.
    Han S; Ha SY; Park CK; Joh JW; Kwon CH; Kwon GY; Kim G; Gwak MS; Jeong WK; Ko JS
    J Hepatol; 2015 Mar; 62(3):556-62. PubMed ID: 25450710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection.
    Jadlowiec CC; Morgan PE; Nehra AK; Hathcock MA; Kremers WK; Heimbach JK; Wiesner RH; Taner T
    Liver Transpl; 2019 Mar; 25(3):425-435. PubMed ID: 30615251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-Year Recipient Morbidity of Liver Transplantation Using Pure Laparoscopic Versus Open Living Donor Right Hepatectomy: Propensity Score Analysis.
    Park J; Kwon CHD; Choi GS; Lee SK; Kim JM; Oh J; Chung YJ; Kim KS; Lee JS; Lee KW; Kim GS; Gwak MS; Ko JS; Kwon JH; Kim K; Lee SH; Joh JW
    Liver Transpl; 2019 Nov; 25(11):1642-1650. PubMed ID: 31271699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.
    Yunhua T; Weiqiang J; Maogen C; Sai Y; Zhiheng Z; Dongping W; Zhiyong G; Xiaoshun H
    J Clin Monit Comput; 2018 Jun; 32(3):471-479. PubMed ID: 28831767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors.
    Ohara S; Macdonough E; Egbert L; Brooks A; Lizaola-Mayo B; Mathur AK; Aqel B; Reddy KS; Jadlowiec CC
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor.
    Kitajima K; Ogawa Y; Miki K; Kai K; Sannomiya A; Iwadoh K; Murakami T; Koyama I; Nakajima I; Fuchinoue S
    Liver Transpl; 2017 Mar; 23(3):315-323. PubMed ID: 27862900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.